Aspire Pharma Holdings Limited
Company profile · London
DissolvedUnited KingdomIncorporated 2014
Financial snapshot
Full financialsPeriod ended 2020-12-31GBPunknown accounts
Net assets
£2.55mLatest reporting periodCash at bank
£238.15kLatest reporting periodTurnover
Not availableNot in extracted metricsEmployees
5Latest reporting periodBalance sheet
GBP · unknownInsufficient comparable history
At least two periods with a known, matching scope are required.
Inspect coverageCompany record
- Company number
- 09306251
- Incorporated
- 2014-11-11
- Legal form
- Unavailable
- Registered office
- 6TH FLOOR, 2, LONDON WALL PLACE, LONDON, EC2Y 5AU
- SIC codes
- 23112
People & control
View all7Current role holders1Control records without an end date0Outstanding security records
OfficerOther current roles
Craig Podolskydirector
9Jonathan Maydirector
12Gary Buckleydirector
12Jacqueline Fraser Pyesecretary
1Mark Robertsdirector
3Ian Jacobsondirector
0Aphl 1 Limited
Activity timeline
- Charge satisfied
Barclays Bank PLC
- Accounts period ended
GBP · 107 source facts
- Craig Podolsky appointed
director
- Jonathan May appointed
director
- Gary Buckley appointed
secretary
- Gary Buckley appointed
director
Connected companies
Open networkNo downstream companies resolved. Upstream control, where available, is shown in the network.
Capital & security
Public records and extracted accounts. Missing figures are unknown, not zero. Research matches are not necessarily direct awards.